Bluebird’s gene therapy shows strong results in two blood disorders in small trials – STAT
STAT |
Bluebird's gene therapy shows strong results in two blood disorders in small trials
STAT TLANTA — Bluebird Bio (BLUE 1) only discloses gene therapy data on its inherited blood disorder programs twice each year, so expectations — and risks — run high each time the biotech reveals its cards. On Sunday night at the American Society of … bluebird bio Announces Updated Clinical Results from Ongoing … |
